Research News

Join WhatsApp Channel

- Read more about Skin Cancer Drug may Slow Age-Related Deaths
Scientist have found that a drug used to treat skin cancer may slow the onset of age-related deaths by slowing the aging process in fruit flies. The study was printed in the journal Cell.
- Read more about Head and Neck Cancers can be detected by New Test That Uses Blood and Saliva
Head and neck cancers affect nearly 50,000 people in the United States each year. The main risk factors include alcohol, smoking and human papillomavirus (HPV), a common sexually transmitted infection that often goes undetected. Researchers at Johns Hopkins University have developed a new test that uses blood and saliva to detect head and neck cancers. The research is published in Science Translational Medicine.
1 July 2015

Blood Pressure Drug may be Helpful in Cocaine & Alcohol Deaddiction

A drug helpful in treating high blood pressure is now effective in ceasing cocaine and alcohol addiction in animal models. This new research give hopes to millions of addicts around the world. Anti-hypertensive drugs block a particular type of ion channel, which is expressed not only in heart and blood vessels but also in certain brain cells. The researchers found that blocking these ion channels in brain cells, using a drug called isradipine, appears to reverse the rewiring that underlies memories of addiction-associated places. The research is published in the Molecular Psychiatry.
- Read more about Test detects every known human virus from single drop of blood
Researchers have developed a new test that can detect every known human virus that currently or previously infected a person from a single drop of blood. The method developed by Howard Hughes Medical Institute (HHMI) researchers can test for current and past infections with any known human virus, including HIV and hepatitis C.
- Read more about USFDA approved Impax Specialty Pharma's Zomig Nasal Spray for Migraine
The United States Food and Drug Administration has approved Impax Specialty Pharma's Zomig Nasal Spray for treatment of acute migraine with or without aura in pediatric patients who are 12 years and older.
- Read more about Rheumatoid Arthritis Drug Restores Skin Color in Vitiligo Patient
Vitiligo is a common, psychologically devastating condition that causes skin to lose its pigmentation or color. Current treatments, such as steroid creams and light therapy, are not reliably effective in reversing the disease. A new study says, a drug used for treating rheumatoid arthritis has restored skin color in a female patient suffering from vitiligo -- a common, skin condition where portion of skin loses its pigmentation or color. The report was published in JAMA Dermatology.
- Read more about Researchers found Potential cure for Type 2 Diabetes
Researchers from the Laboratory of Cancer Metabolism at IDIBELL found a potential target for the treatment of type 2 diabetes. The study is published in the Journal of Clinical Investigation. Research led by Sara Kozma, have shown in animal models that inhibition of S6K1 protein may be a potential treatment for type 2 diabetes.
- Read more about Gene Reactivation convert Colorectal Cancer Cells into Normal Tissue
Nearly 700,000 people around the world die from colorectal cancer each year. Colorectal cancer is the second leading cause of cancer-related death in developed countries. Anti-cancer therapies generally involve killing off tumor cells. A new study says, now the cancer cells can be turned back into normal tissue simply by reactivating a single gene. The study is published in the Cell.

[adsense:336x280:8701650588]
- Read more about Breakthrough arthritis treatment developed by Aus researchers
Australian researchers have developed a breakthrough vaccine-style therapeutic approach to treat rheumatoid arthritis, a debilitating disease affecting over 450,000 people in the country. Lead researcher Ranjeny Thomas from the University of Queensland's Diamantina Institute said results from the phase one clinical trial demonstrate the new treatment is safe and effective in supressing the immune response.
- Read more about Single shot of Anti-Malaria Drug Immunize Against Malaria
The research conducted by Dundee University, Scotland explained that the newly developed drug could work well against parasites resistant to current treatments of the mosquito-borne disease. Researchers discovered a new compound, DDD107498 to treat malaria in a single dose, protects people from the disease and prevent the transmission of infection. The research is printed in the journal 'Nature'.